IGF Oncology LLC - Company Review
IGF Oncology LLC - Company ReviewSummary
IGF Oncology LLC (IGF) is a healthcare products provider that develops anti-cancer chemotherapy drugs. The company develops anti-cancer chemotherapy drugs offering reduce side effects and improve effectiveness. Its IGF-methotrexate conjugate offers chemotherapy drug methotrexate chemically attached to an engineered form of the hormone insulin-like growth factors. IGF develops other novel drugs based on patent-pending technology that include IGF conjugates with other chemotherapy drugs, therapeutic radioactive isotopes, and toxins. The company also offers technology development and provides clinical trial services. IGF is headquartered in St. Paul, Minnesota, the US.
This comprehensive company report of IGF Oncology LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.